Giuseppe Milone

21PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)HaematologyHaematological tumoursPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 02, 2026
Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

|Jul 12, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster Dose.

Uros Markovic, Elvira Scalisi, Giuliana Giunta

|Nov 27, 2024
A New Tool Supporting the Selection of the Best Hematopoietic Stem Cell Donor by Modelling Local Own Real-World Data.

Roberto Crocchiolo, Stefania Cacace, Giuseppe Milone

|Aug 21, 2024
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.

Gianluca Cavallaro, Anna Grassi, Chiara Pavoni

|Jul 27, 2024
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease.

Lucia Gozzo, Salvatore Leotta, Giovanni Luca Romano

|Oct 24, 2023
Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin Lymphoma.

Andrea Duminuco, Marina Parisi, Giulio Antonio Milone

Pageof 4

Frequent Collaborators

6 joint publications

Andrea Duminuco

5 joint publications

Salvatore Leotta

3 joint publications

Francesca Bonifazi

3 joint publications

Giuseppe Alberto Palumbo